Home » Shire Web-Based Dosing Software Achieves FDA Clearance
Shire Web-Based Dosing Software Achieves FDA Clearance
Shire received 510(k) marketing clearance for its web-based dosing software for patients with hemophilia A treated with ADVATE.
The mPKFit estimates a patient’s pharmacokinetic profile using just two measurable blood samples — compared to the 9 to 11 samples recommended by the International Society on Thrombosis and Haemostasis — enabling clinicians to tailor treatments to the individual patients.
The severity of hemophilia A is determined by assessing the amount of factor in the blood, with more severity associated with lower amounts of factor.
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May